Part 4: Metastatic prostate cancer and HRR defects

Part 5: BRCA 1/2 mutations and prostate cancer

The role of testing in prostate cancer treatment

Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)

OncoAlert and ecancer weekly round up for July 1- July 10, 2021

ASCO 2021: Precision and molecular reporting for prostate cancer

JAVELIN Bladder 100: Avelumab first-line maintenance plus best supportive care (BSC) versus BSC alone for advanced UC

PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible patients with muscle-invasive bladder cancer

OncoAlert and ecancer ASCO roundup - Day 4 and 5